VTP-43742

VTP-43742 · Vitae Pharmaceuticals Inc., an Allergan affiliate

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VTP-43742, covering 2018-10-30 to 2018-10-30. Get the full timeline:

Most recent: Clinical Trial Update: An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients [Phase 1, Phase 2]